Hercules Capital Price to Free Cash Flow Ratio 2010-2024 | HTGC
Historical price to free cash flow ratio values for Hercules Capital (HTGC) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Hercules Capital Price to Free Cash Flow Ratio Historical Data |
Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
2024-11-12 |
19.80 |
|
58.39 |
2024-09-30 |
19.64 |
$0.34 |
57.92 |
2024-06-30 |
19.92 |
$-1.03 |
0.00 |
2024-03-31 |
17.53 |
$-0.47 |
0.00 |
2023-12-31 |
15.43 |
$0.47 |
33.16 |
2023-09-30 |
14.75 |
$-1.00 |
0.00 |
2023-06-30 |
12.91 |
$-0.52 |
0.00 |
2023-03-31 |
10.86 |
$-2.35 |
0.00 |
2022-12-31 |
10.81 |
$-3.35 |
0.00 |
2022-09-30 |
9.14 |
$-1.92 |
0.00 |
2022-06-30 |
10.30 |
$-1.27 |
0.00 |
2022-03-31 |
13.38 |
$-0.05 |
0.00 |
2021-12-31 |
11.94 |
$1.11 |
10.78 |
2021-09-30 |
11.69 |
$2.31 |
5.06 |
2021-06-30 |
11.74 |
$1.87 |
6.28 |
2021-03-31 |
10.78 |
$1.64 |
6.58 |
2020-12-31 |
9.47 |
$1.85 |
5.12 |
2020-09-30 |
7.38 |
$-0.42 |
0.00 |
2020-06-30 |
6.50 |
$0.06 |
108.84 |
2020-03-31 |
4.59 |
$-1.13 |
0.00 |
2019-12-31 |
8.18 |
$-2.38 |
0.00 |
2019-09-30 |
7.61 |
$-3.70 |
0.00 |
2019-06-30 |
7.11 |
$-4.21 |
0.00 |
2019-03-31 |
6.85 |
$-4.95 |
0.00 |
2018-12-31 |
5.84 |
$-2.74 |
0.00 |
2018-09-30 |
6.78 |
$-2.36 |
0.00 |
2018-06-30 |
6.37 |
$-2.12 |
0.00 |
2018-03-31 |
5.95 |
$0.37 |
15.89 |
2017-12-31 |
6.28 |
$-0.23 |
0.00 |
2017-09-30 |
6.04 |
$-0.16 |
0.00 |
2017-06-30 |
6.05 |
$0.07 |
89.11 |
2017-03-31 |
6.75 |
$-0.58 |
0.00 |
2016-12-31 |
6.17 |
$-1.88 |
0.00 |
2016-09-30 |
5.79 |
$-1.34 |
0.00 |
2016-06-30 |
5.19 |
$-0.25 |
0.00 |
2016-03-31 |
4.89 |
$-1.02 |
0.00 |
2015-12-31 |
4.83 |
$-1.64 |
0.00 |
2015-09-30 |
3.89 |
$-0.99 |
0.00 |
2015-06-30 |
4.34 |
$-2.19 |
0.00 |
2015-03-31 |
4.94 |
$-2.77 |
0.00 |
2014-12-31 |
5.33 |
$-0.42 |
0.00 |
2014-09-30 |
5.08 |
$1.10 |
4.60 |
2014-06-30 |
5.57 |
$2.49 |
2.23 |
2014-03-31 |
4.74 |
$3.17 |
1.50 |
2013-12-31 |
5.42 |
$1.71 |
3.16 |
2013-09-30 |
4.95 |
$-2.06 |
0.00 |
2013-06-30 |
4.44 |
$-4.60 |
0.00 |
2013-03-31 |
3.82 |
$-4.46 |
0.00 |
2012-12-31 |
3.40 |
$-3.95 |
0.00 |
2012-09-30 |
3.29 |
$-3.37 |
0.00 |
2012-06-30 |
3.31 |
$-4.57 |
0.00 |
2012-03-31 |
3.17 |
$-4.18 |
0.00 |
2011-12-31 |
2.64 |
$-3.23 |
0.00 |
2011-09-30 |
2.33 |
$-2.91 |
0.00 |
2011-06-30 |
2.81 |
$-0.34 |
0.00 |
2011-03-31 |
2.87 |
$-1.62 |
0.00 |
2010-12-31 |
2.65 |
$-2.54 |
0.00 |
2010-09-30 |
2.54 |
$0.48 |
5.28 |
2010-06-30 |
2.27 |
$1.38 |
1.64 |
2010-03-31 |
2.56 |
$4.65 |
0.55 |
2009-12-31 |
2.46 |
$6.47 |
0.38 |
Sector |
Industry |
Market Cap |
Revenue |
Finance |
Finance - SBIC & Commercial |
$3.244B |
$0.461B |
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
|